BACKGROUND: florio HAEMO is a new hemophilia treatment monitoring application consisting of a patient smartphone application (app) and a web-based dashboard for healthcare professionals, providing several novel features, including activity tracking, wearable connectivity, kids and caregiver mode, and real-time pharmacokinetic factor level estimation. OBJECTIVES: To assess intuitiveness, ease-of-use, and patient preference of florio HAEMO in Central Europe using a cross-sectional survey. METHODS: This survey was conducted in six Central European countries between 9 December 2020 and 24 May 2021. The online questionnaire included 17 questions about overall satisfaction, ease-of-use, intuitiveness, and patient preference. Adults or children with hemophilia on regular prophylaxis and using the florio HAEMO app for a minimum of 1 week were invited to complete the online questionnaire by their treating physician. RESULTS: Sixty-six participants took part in the survey. The median duration for all respondents using the florio HAEMO app was 3 to 4 weeks. Overall, 89.4% of users reported being very satisfied or rather satisfied after using florio HAEMO. Of the 23 respondents who had switched from another hemophilia app, 87.0% indicated that they strongly preferred or preferred using florio HAEMO. Most florio HAEMO users reported that the app was very easy or rather easy to use (97.0%) and intuitive (94.0%). florio HAEMO had a positive impact on daily living, with 78.8% of users reporting that the app was very important or rather important to them. CONCLUSIONS: This survey suggests that florio HAEMO is an easy-to-use and intuitive app to assist self-management of home prophylaxis.

Blood Center University Hospital Ostrava Ostrava Czech Republic

Department of Hematology and Oncology University Children's Hospital University Medical Center Ljubljana Ljubljana Slovenia

Department of Hematology University Medical Center Ljubljana Faculty of Medicine University of Ljubljana Ljubljana Slovenia

Department of Pediatric Hematology and Biochemistry Masaryk University and University Hospital Brno Brno Czech Republic

Department of Pediatric Hematology Oncology University Hospital Motol 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Pediatrics Division of Hematology and Oncology University Hospital Center Zagreb Zagreb Croatia

Department of Pediatrics Hematology and Oncology Warsaw Medical University Warsaw Poland

Division of Hematology Department of Internal Medicine University Hospital Center Zagreb School of Medicine University of Zagreb Zagreb Croatia

Hemato oncology Unit Heim Pal Children's Hospital Budapest Hungary

HZRM Hamophilie Zentrum Rhein Main Mörfelden Walldorf Germany

Medical Center of Hungarian Defense Forces Budapest Hungary

National Hemophilia Center Department of Hematology and Transfusion Medicine Faculty of Medicine of Comenius University and University Hospital Bratislava Slovakia

Swedish Orphan Biovitrum AG Basel Switzerland

See more in PubMed

Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia. Haemophilia. 2020;26(S6):1‐158. PubMed

Walker I, Sigouin C, Sek J, et al. Comparing hand‐held computers and paper diaries for haemophilia home therapy: a randomized trial. Haemophilia. 2004;10(6):698‐704. PubMed

Mondorf W, Siegmund B, Mahnel R, et al. Haemoassist™– a hand‐held electronic patient diary for haemophilia home care. Haemophilia. 2009;15(2):464‐472. PubMed

Tiede A, Bonanad S, Santamaria A, et al. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: systematic assessments from an electronic diary. Haemophilia. 2020;26(6):999‐1008. PubMed

Hay CRM, Xiang H, Scott M, et al. The haemtrack home therapy reporting system: design, implementation, strengths and weaknesses: a report from UK Haemophilia Centre Doctors Organisation. Haemophilia. 2017;23(5):728‐735. PubMed

Arvanitakis A, Berntorp E, Astermark J. A comparison of MyPKFiT and WAPPS‐Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa. Haemophilia. 2021;27(3):417‐424. PubMed

Mondorf W, Eichler H, Fischer R, et al. Smart Medication™, an electronic diary for surveillance of haemophilia home care and optimization of resource distribution. Hamostaseologie. 2019;39(4):339‐346. PubMed

Haemophilia Foundation Western Australia . What is MyABDR. 2021. Accessed December 2021. https://www.hfwa.org/about‐bleeding‐disorders/myabdr/what‐is‐myabdr

Decker K, Meilleur C. CBDR and MyCBDR: advancing hemophilia nursing practice in Canada. Poster (T‐P‐19) presented at the World Federation of Hemophilia (WFH) Congress; May 20‐24, 2018; Glasgow, United Kingdom.

McMaster University . Wapps‐Hemo. 2021. Accessed December 2021. https://www.wapps‐hemo.org/

MicroHealth Inc . MicroHealth digital hematology. 2021. Accessed December 2021. https://microhealth.com/

Iorio A, Edginton A, Blanchette V, et al. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: rationale and general considerations. Res Pract. Thromb Haemost. 2018;2:535‐548. PubMed PMC

Iorio A, Blanchette V, Blatny J, Collins P, Fischer K, Neufeld E. Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH. J Thromb Haemost. 2017;15(12):2461‐2465. PubMed

Hermans C, Dolan G. Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities—a practical review. Ther Adv Hematol. 2020;11:1‐15. PubMed PMC

Abrantes JA, Solms A, Garmann D, Nielsen EI, Jönsson S, Karlsson MO. Bayesian forecasting utilizing bleeding information to support dose individualization of Factor VIII. CPT Pharmacometrics Syst Pharmacol. 2019;8(12):894‐903. PubMed PMC

McMaster PopPK . McMaster PopPK user manual. 2021. Accessed June 30, 2021. https://s3.wasabisys.com/mywappsnews/2020/07/MacPopPK‐User‐Manual‐v2.1.pdf

Hacker MR, Primeaux J, Manco‐Johnson MJ. A patient satisfaction survey for haemophilia treatment centres. Haemophilia. 2006;12(2):163‐168. PubMed

Salisbury C, Thomas C, O'Cathain A, et al. TElehealth in CHronic disease: mixed‐methods study to develop the TECH conceptual model for intervention design and evaluation. BMJ Open. 2015;5(2):e006448. PubMed PMC

Hughes T, Brok‐Kristensen M, Gargeya Y, et al. What more can we ask for? An ethnographic study of challenges and possibilities for people living with haemophilia. J Haem Prac. 2020;7:25‐36.

Iorio A. Using pharmacokinetics to individualize hemophilia therapy. Hematology. 2017;2017(1):595‐604. PubMed PMC

European Union . Socio‐economic impact of mHealth – an assessment report for the European Union. 2013. Accessed March 18, 2021. https://www.gsma.com/iot/wp‐content/uploads/2013/06/Socio‐economic_impact‐of‐mHealth_EU_14062013V2.pdf

Clarke PM, Fiebig DG, Gerdtham UG. Optimal recall length in survey design. J Health Econ. 2008;27(5):1275‐1284. PubMed

Teenagers and Adolescents with Hemophilia-Need for a Specific Approach

florio® HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe